Marshall Islands vs Myanmar: Hypertension: effective treatment coverage (controlled hypertension)
Marshall Islands
14.5%
in 2019
Myanmar
14.9%
in 2019
Marshall Islands rank
113th
Myanmar rank
110th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Marshall Islands
- Myanmar
How they compare
Myanmar currently reports 14.9% against 14.5% in Marshall Islands, a difference of 0.4%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Marshall Islands ahead.
Marshall Islands ranks 113th and Myanmar ranks 110th of 193 countries.
Marshall Islands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Marshall Islands | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 9.8% | 4.4% | 5.4% | Marshall Islands |
| 2000s | 13.0% | 8.0% | 5.0% | Marshall Islands |
| 2010s | 14.6% | 13.0% | 1.6% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Marshall Islands or Myanmar?
- Myanmar, at 14.9% against 14.5% in Marshall Islands as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Marshall Islands and Myanmar?
- 0.4%, with Myanmar ahead.
- How many years of comparable data are there for Marshall Islands and Myanmar?
- 30 years are reported by both, from 1990 to 2019.
- How do Marshall Islands and Myanmar rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Marshall Islands ranks 113th and Myanmar ranks 110th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.